PARAINFLUENZA 1, 2, 3, 4 RNA DETECTION (QUALITATIVE PCR)

The PARAINFLUENZA 1, 2, 3, 4 RNA DETECTION (QUALITATIVE PCR) is a clinically validated molecular test that detects the presence of parainfluenza virus RNA from respiratory specimens using real-time PCR. It provides a qualitative result — indicating whether RNA from parainfluenza types 1 through 4 is detected or not — enabling accurate identification of viral infection as the cause of acute respiratory symptoms.

This test is used to confirm parainfluenza infection in patients with fever, cough, wheeze or bronchiolitis, and is particularly useful for children, elderly patients, and immunocompromised individuals. With Dubai home sample collection and rapid laboratory turnaround, results support prompt clinical decisions, appropriate isolation or infection-control measures, and targeted supportive care.

Limitations include that the assay is qualitative (it does not provide viral load) and a negative result may occur with poor sampling or if testing is performed late in the illness; clinical correlation and physician consultation are recommended. Samples are typically nasopharyngeal swabs collected by trained personnel; results are delivered securely to the ordering clinician or patient, usually within the stated rapid turnaround time.

• Parainfluenza virus 1 RNA (Qualitative)
• Parainfluenza virus 2 RNA (Qualitative)
• Parainfluenza virus 3 RNA (Qualitative)
• Parainfluenza virus 4 RNA (Qualitative)

• Acute onset of fever with cough, sore throat or wheezing
• Bronchiolitis or pneumonia in infants and young children
• Severe respiratory symptoms in elderly or immunocompromised patients
• Suspected viral outbreak in schools, nurseries, or communal settings
• Close contact with a confirmed parainfluenza case and development of symptoms

• Rapid and sensitive detection of parainfluenza types 1–4
• Enables timely clinical management and infection-control decisions
• Home sample collection across Dubai for patient convenience
• Clinically validated PCR methodology for high diagnostic accuracy
• Reduces need for immediate hospital visits and supports remote care

• Nasopharyngeal swab collection performed by a trained professional at home
• No fasting required; normal medications may be continued unless instructed
• Patient should be available and provide valid UAE ID and consent at appointment
• Inform collector of recent symptoms onset, contacts, and any immunosuppression